合成MRI参数与乳腺癌异质性:一项定量研究
该回顾性研究纳入582例经病理确诊的乳腺癌患者,术前采用3.0 T磁共振MAGiC序列行合成MRI,提取肿瘤区定量T1、T2、PD及增强后T1值,分析其与ER、PR、HER2、Ki-67、组织学分级及肿瘤大小、背景实质强化、纤维腺体组织等影像特征的关系,发现组织学分级对定量参数影响最大。
要点
- 组织学分级高、ER阴性、PR阴性、HER2阳性的乳腺癌,其合成MRI定量T1、T2、PD及增强后T1值均显著更高。
- Ki-67高表达与T1、T2及增强后T1值升高相关,但与PD无关。
- 组织学分级对增强后T1(η²=0.132)和T2(η²=0.075)的影响为中等效应,是解释定量参数时最主要的混杂因素。
核心结论
- 合成MRI衍生的定量指标与乳腺癌病理及影像特征相关;效应量分析提示组织学分级是解释定量合成MRI参数时影响最大的混杂因素。
研究设计与样本
- 回顾性研究,纳入582例经病理确诊的乳腺癌患者,术前在3.0 T扫描仪上行合成MRI(MAGiC序列),提取肿瘤区定量T1、T2、PD及增强后T1(T1C)值,并与临床病理数据及影像特征进行组间比较。
关键影像表现/征象
- 组织学分级高、ER阴性、PR阴性及HER2阳性的乳腺癌亚组,T1、T2、PD及增强后T1值均显著更高(P < 0.05)。
- Ki-67高表达与T1、T2及增强后T1值升高相关,但与PD无关。
- 肿瘤较大(>2 cm)与T1、T2及增强后T1值升高相关。
- 纤维腺体组织致密及背景实质强化高的患者PD值升高,而纤维腺体组织低的患者T2值略高。
诊断标准与关键数值
- 组织学分级对增强后T1的效应量为η² = 0.132,对T2的效应量为η² = 0.075,属中等效应。
- 其他特征的效应量均为小或可忽略(η² < 0.06)。
临床应用与阅片要点
- 解读乳腺合成MRI定量参数时,组织学分级是影响最大的混杂因素,应在报告中结合病理分级综合判断。
- 肿瘤大小、ER/PR/HER2状态、Ki-67及背景实质强化、纤维腺体组织等特征也可能影响定量参数,但效应量较小或可忽略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To explore the associations between synthetic MRI (SyMRI)-derived quantitative parameters and histopathological and imaging features in breast cancer, and to identify potential confounding factors affecting parameter interpretation.
METHODS: In this retrospective study, 582 patients with pathologically confirmed breast cancer who underwent preoperative SyMRI (MAGiC sequence) on a 3.0 T scanner were included. Quantitative T1, T2, PD, and post-contrast T1 (T1C) values were extracted from tumor regions. Clinicopathological data (ER, PR, HER2, Ki-67, histological grade) and imaging features (tumor size, background parenchymal enhancement [BPE], fibroglandular tissue [FGT]) were collected and analyzed. Two-sample t-tests or Mann-Whitney U tests were used for intergroup comparisons. Effect sizes (η²) were calculated to quantitatively evaluate the clinical relevance and strength of associations.
RESULTS: Tumors of high histological grade and those in the ER-negative, PR-negative, and HER2-positive subgroups demonstrated significantly higher T1, T2, PD, and T1C values (P < 0.05). High Ki-67 expression was associated with increased T1, T2, and T1C values, but not with PD. Larger tumor size (>2 cm) was associated with higher T1, T2, and T1C values. PD values were elevated in patients with dense FGT and high BPE, whereas T2 values were slightly higher in those with low FGT. Effect size analysis revealed that histological grade had a moderate effect on T1C (η² = 0.132) and T2 (η² = 0.075), while the other features exhibited only small or negligible effects (η² < 0.06).
CONCLUSION: SyMRI-derived quantitative metrics are associated with both pathological and imaging features. Effect size analysis highlights histological grade as the most influential confounding factor in the interpretation of quantitative SyMRI.
引用
- Wang J, Li Y, Ma X, et al. Synthetic MRI Parameters and Breast Cancer Heterogeneity: A Quantitative Study. Acad Radiol. 2025. PMID: 41276434. doi:10.1016/j.acra.2025.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。